Kory Wentworth
Director of Finance/CFO bei ENTRADA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Kory James Wentworth is currently the Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. Prior to this, he worked as the Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. from 2008 to 2017 and as the Treasurer & Vice President-Finance at bluebird bio, Inc. from 2017 to 2020.
He completed his undergraduate degree at Susquehanna University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0,25% | 15.03.2024 | 83 170 ( 0,25% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Kory Wentworth
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director of Finance/CFO | 01.11.2020 |
Ehemalige bekannte Positionen von Kory Wentworth
| Unternehmen | Position | Ende |
|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 08.09.2020 |
| ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 01.12.2017 |
Ausbildung von Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
